By expanding access to high-performance, easy to use molecular diagnostics, we enable clinicians to get accurate and timely results at the point of care.
Location: United States, California, Menlo Park
Employees: 51-200
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | CARB-X | carb-x.org |
Mentions in press and media 4
| Date | Title | Description |
| 26.04.2022 | Point of Care Testing Market to Account for US$ 66 Bn Valuation by 2028: Fact.MR Analysis Predicts | United States, Rockville, MD, April 26, 2022 (GLOBE NEWSWIRE) -- In 2020, the point of care diagnostics market was worth US$ 34.1 Bn, and is projected to surge to an impressive estimated valuation of US$ 66 Bn by 2028. Increasing number of ... |
| 26.04.2022 | Point of Care Testing Market to Account for US$ 66 Bn Valuation by 2028: Fact.MR Analysis Predicts | Point of Care (PoC) Testing Market Analysis by Platform (Lateral Flow Assays-based POC Tests, Dipsticks POC, Molecular Diagnostics), by Application (Glucose Monitoring, Cardiometabolic Monitoring, Infectious Disease Testing), by End User &a... |
| 12.11.2020 | Talis Expands Executive Team and Closes Additional Financing in Preparation for Commercial Launch of Talis One™ System | |
| - | Home Equity Platform Company Point Raises $115 Million In Series C | Point recently announced it raised $115 million in Series C funding. These are the details. Point – a fintech company and home equity platform that provides homeowners access to equity financing in exchange for a fractional share of the fut... |